Return to content in this issue

Exacerbation Rate Reduction With Mepolizumab Stratified by Maintenance Oral Corticosteroids Use and Eosinophil Levels: A Post Hoc Analysis of the DREAM and MENSA Studies

Bobolea I¹, Bañas D², Melero C³, de Andrés AI², Joksaite S², Sánchez-Herrero G<sup>2

1</sup>Allergy Section, Severe Asthma Unit. Department of Pulmonology and Allergy, Hospital Clinic Barcelona–Institute for Health Research (IdiBAPS), Barcelona, Spain
²GSK, Madrid, Spain
³Hospital 12 de Octubre Institute for Health Research (i+12), Madrid, Spain

J Investig Allergol Clin Immunol 2022; Vol 32(2) : 148-150
doi: 10.18176/jiaci.0714